Navigation Links
UltraTape Announces Sample Kits Available for Purchase Through Website
Date:4/22/2008

SALEM, Ore., April 22 /PRNewswire/ -- UltraTape Industries, a division of Delphon Industries and manufacturer of adhesive tapes for critical environments, announced today the availability of sample kits for purchase through their website http://www.cleanroomtape.com. There are currently 5 sample kits available including those designed for General Purpose Cleanroom Tapes, Cleanroom Construction Tapes, ESD Tapes, Medical and Pharmaceutical Tapes, and Wafer Box Sealing Tapes. Each kit contains a variety of tape samples with different levels of adhesion, carrier films, and adhesive types that are appropriate for a particular application.

"Making these kits available for purchase online is part of our ongoing effort to more effectively service our customers," says Keith Taft, UltraTape General Manager. "Customers will now be able to purchase these tapes and evaluate them to see which one is appropriate for their specific application." UltraTape specializes in particle and residue free adhesive tapes that are required for semiconductor and medical applications.

Background:

UltraTape, founded in 1992 and purchased by Delphon Industries in 2007, manufactures custom cleanroom construction and semiconductor process tapes in addition to antistatic and medical/pharmaceutical tapes for use in critical environments.

About Delphon:

UltraTape is a division of Delphon Industries, LLC. Delphon's mission is to provide materials and services for the shipping, processing, and packaging of high value technology and medical components. Headquartered in Hayward, California, CEO Jeanne Beacham has aggressively positioned Delphon to take advantage of changes within the industries the company serves.

With Divisions Gel-Pak, Quik-Pak, TouchMark and UltraTape along with a worldwide sales and distribution network, Delphon Industries serves a wide range of markets including the Semiconductor,
'/>"/>

SOURCE UltraTape Industries
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
2. YM BIOSCIENCES ANNOUNCES COMPLIANCE WITH AIM RULE 26
3. Emisphere Technologies, Inc. Announces Pricing of Registered Direct Offering
4. BioLife Solutions Announces Exclusive CryoStor(TM) Supply Agreement With the New England Cryogenic Center, Inc.
5. Carrington Announces Nasdaq Communication; Prepares for Shares to Be Quoted on the OTC Bulletin Board and Pink Sheets
6. China Kangtai Cactus Biotech Files 2nd Quarter 2007 10QSB and Announces Unaudited Quarterly Results
7. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
8. Advanced Life Sciences Announces Receipt of Nasdaq Staff Letter
9. ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer
10. Angiotech announces additional diameters of sutures to further expand its Quill(TM) SRS PDO product line
11. CNS Response Announces Fiscal Third Quarter 2007 Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/27/2015)... , August 27, 2015 GlassesOff ... image processing functions in the human vision system, announced today ... point guard Chris Paul to develop a ... who want to improve their real-life on-court performance. ... court, whether it is shooting a ball or blocking a ...
(Date:8/27/2015)... (PRWEB) , ... August 27, 2015 , ... ... customers’ weighing needs and expertly narrows down the product choices to a manageable ... criteria pares down the list to models that fit best with the customer’s ...
(Date:8/27/2015)... Irvine, CA (PRWEB) , ... August 27, 2015 ... ... leader in Personalized Medicine, recently presented new data on the relationship of genetics ... 2015 20th World Congress on Heart Disease in Vancouver, British Columbia, Canada. The ...
(Date:8/26/2015)... - iCo Therapeutics ("iCo" or "the Company") (TSX-V: ICO) ... quarter ended June 30, 2015. Amounts, unless specified ... under International Financial Reporting Standards ("IFRS"). ... Oral Amp B program, rapidly advancing towards the ... Rae , President & CEO of iCo Therapeutics. "We ...
Breaking Biology Technology:Eight-Time All-Star Chris Paul and GlassesOff Partner to Develop Innovative Mobile App Designed to Improve On-Court Performance 2Eight-Time All-Star Chris Paul and GlassesOff Partner to Develop Innovative Mobile App Designed to Improve On-Court Performance 3METTLER TOLEDO Updates Online Scale Selection Tool 2Proove Biosciences Presents Ground-Breaking Data on Genetics and Heart Disease at 20th World Congress on Heart Disease 2Proove Biosciences Presents Ground-Breaking Data on Genetics and Heart Disease at 20th World Congress on Heart Disease 3iCo Therapeutics Announces Second Quarter 2015 Financial Results 2iCo Therapeutics Announces Second Quarter 2015 Financial Results 3
... April 23 Government and private insurers are placing ... for the products they develop, according to The 2009 ... governments and individuals are likely to increase demands to ... mounting healthcare costs, a shrinking tax base, aging populations, ...
... /PRNewswire-Asia-FirstCall/ --, - Fourth Quarter 2008 Revenue Increased 28.6% to ... and Diluted EPS of $.03, - 2008 Revenues Increased 23.5% ... Improved 340 Basis Points to 20.1%, - 2008 Net Income ... $0.13, - 2008 Cash Flow from Operations was $5.9 ...
... 2009 came to a close were forced to announce layoffs, and the U.S. ... rest of the country as job creation for March contracted by 50 percent. ... ... came to a close in March, several companies announced layoffs, and while many ...
Cached Biology Technology:Failing to Demonstrate Value of Innovation is Top Risk Facing Life Sciences Sector, According to Ernst & Young 2Failing to Demonstrate Value of Innovation is Top Risk Facing Life Sciences Sector, According to Ernst & Young 3Failing to Demonstrate Value of Innovation is Top Risk Facing Life Sciences Sector, According to Ernst & Young 4China Yongxin Pharmaceuticals, Inc. Announces 2008 Fourth Quarter and Full Year Financial Results 2China Yongxin Pharmaceuticals, Inc. Announces 2008 Fourth Quarter and Full Year Financial Results 3China Yongxin Pharmaceuticals, Inc. Announces 2008 Fourth Quarter and Full Year Financial Results 4China Yongxin Pharmaceuticals, Inc. Announces 2008 Fourth Quarter and Full Year Financial Results 5China Yongxin Pharmaceuticals, Inc. Announces 2008 Fourth Quarter and Full Year Financial Results 6China Yongxin Pharmaceuticals, Inc. Announces 2008 Fourth Quarter and Full Year Financial Results 7China Yongxin Pharmaceuticals, Inc. Announces 2008 Fourth Quarter and Full Year Financial Results 8China Yongxin Pharmaceuticals, Inc. Announces 2008 Fourth Quarter and Full Year Financial Results 9China Yongxin Pharmaceuticals, Inc. Announces 2008 Fourth Quarter and Full Year Financial Results 10China Yongxin Pharmaceuticals, Inc. Announces 2008 Fourth Quarter and Full Year Financial Results 11The MedZilla Report: March 2009 Employment Outlook for Biotech/Pharma/Health 2The MedZilla Report: March 2009 Employment Outlook for Biotech/Pharma/Health 3The MedZilla Report: March 2009 Employment Outlook for Biotech/Pharma/Health 4
(Date:8/5/2015)... VIEW, Calif. , Aug. 5, 2015 ... exhibits continuous growth in applications, penetration into newer sectors, ... after year. The global biosensors space has seen the ... exited the market so far. (Photo - ... Frost & Sullivan, Analysis of the Global Biosensors ...
(Date:7/31/2015)... , 31 de julio de 2015 ... (ICG-10,  www.icg-10.org ) del 22 al 25 de octubre ... La conferencia celebra su décimo aniversario este ... convertido en una de las reuniones anuales más influyentes ... es una de las conferencias científicas más dinámicas, entusiastas ...
(Date:7/31/2015)... Jul. 31, 2015 NXT-ID, Inc. (NASDAQ: NXTD ... focused on the growing mobile commerce market and creator ... filed provisional patent 62/198989 for ELECTRONIC CRYPTO-CURRENCY ... a method to advance crypto-currencies such as Bitcoin into ... common, uniform way to manage all payments.  ...
Breaking Biology News(10 mins):Innovative Biosensors Incite Use in Non-Traditional Applications 2Innovative Biosensors Incite Use in Non-Traditional Applications 3Innovative Biosensors Incite Use in Non-Traditional Applications 4La 10ª Conferencia Internacional sobre Genómica (ICG-10) comienza en octubre 2La 10ª Conferencia Internacional sobre Genómica (ICG-10) comienza en octubre 3NXT-ID Patents Electronic Crypto-Currency Management Technology 2NXT-ID Patents Electronic Crypto-Currency Management Technology 3NXT-ID Patents Electronic Crypto-Currency Management Technology 4
... the Appalachian Mountains is a tiger swallowtail butterfly that ... ago. It,s a rarity in the animal world, ... tiger swallowtail, Papilio appalachiensis, evolved from mixing between the ... and the Canadian tiger swallowtail, P. canadensis . ...
... HOUSTON -- Gene therapy delivered directly to a particularly ... to self-destruct, lowers chance of recurrence and helps increase ... The University of Texas MD Anderson Cancer Center reported ... . In cellular and mouse studies, scientists found ...
... 12, 2011A study presented today by Universit Laval researchers at ... Quebec City revealed that the risk of insomnia is 67% ... member is an insomniac. The research team, directed ... Psychology, came to these conclusions following a study involving 3,485 ...
Cached Biology News:A tale of (more than) 2 butterflies 2A tale of (more than) 2 butterflies 3Gene therapy kills breast cancer stem cells, boosts chemotherapy 2Gene therapy kills breast cancer stem cells, boosts chemotherapy 3
Recognizes Kir4.1. The epitope does not share homology with any other known proteins.,SPECIES REACTIVITIES: The antibody is also expected to work with mouse and human due to sequence homology. Oth...
Evi-1 Antibody Shipping Temperature: Cold Storage Temperature: -20C...
Profilin-1/2 (FL-140)...
Immunogen: Synthetic peptide: N(171) H G F L S A D Q QL I K(183) Storage: -20 C, Avoid Freeze/Thaw Cycles...
Biology Products: